Literature DB >> 18798827

Hs-CRP is associated with weight, BMI, and female sex but not with endothelial function in children with type 1 diabetes.

Karen E MacKenzie1, Esko J Wiltshire, Alexia S Peña, Roger Gent, Craig Hirte, Lino Piotto, Jennifer J Couper.   

Abstract

BACKGROUND: Atherosclerosis is an inflammatory process, and high-sensitivity C-reactive protein (Hs-CRP), a marker of inflammation, predicts cardiovascular events in adults. Vascular endothelial and smooth muscle dysfunction, measurable precursors of atherosclerosis, begin in childhood. Therefore, we sought to determine if Hs-CRP is associated with vascular endothelial and smooth muscle dysfunction in children with type 1 diabetes mellitus (T1DM) and healthy control subjects.
METHODS: Hs-CRP and endothelial function assessed by flow-mediated dilatation (FMD) and smooth muscle function assessed by glyceryl-trinitrate (GTN)-induced dilatation were measured in 121 subjects with T1DM aged 14.1 (2.9) yr, of whom 31 were also studied at 4 and 8 wk, and in 33 healthy controls aged 14.2 (3.6) yr.
RESULTS: Hs-CRP did not differ between subjects with T1DM and healthy, age-matched controls. In both controls and subjects with T1DM, Hs-CRP did not relate to FMD or GTN at baseline or at intervals over 8 wk in T1DM. Hs-CRP did not change over time. In T1DM, but not healthy controls, Hs-CRP related to body mass index (BMI) z-score (r = 0.47, p < 0.001), weight z-score (r = 0.41, p < 0.001), and female sex (p = 0.008).
CONCLUSIONS: Hs-CRP is not associated with early vascular dysfunction in children with T1DM. However, in children and adolescents with T1DM, Hs-CRP was associated with female sex and children with higher BMI, suggesting that these groups may be at greater cardiovascular risk. Maintenance of a healthy BMI may be important in the prevention of vascular disease of T1DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798827     DOI: 10.1111/j.1399-5448.2008.00456.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  7 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

2.  Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.

Authors:  Ian B McKittrick; Yolanda Bogaert; Kristen Nadeau; Janet Snell-Bergeon; Amber Hull; Tao Jiang; Xiaoxin Wang; Moshe Levi; Karen S Moulton
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-14

3.  Arterial stiffness is not increased in teens with early uncomplicated type 1 diabetes mellitus.

Authors:  Mei-Ching Yu; Fu-Sung Lo; Meng-Kung Yu; Wen-Hung Huang; Fan Lee
Journal:  Eur J Pediatr       Date:  2012-05       Impact factor: 3.183

4.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

5.  Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus.

Authors:  Damla Gökşen; Ertürk Levent; Sakine Kar; Samim Ozen; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

6.  Association between Circulating Irisin and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis.

Authors:  Elham Eslampour; Farzad Ebrahimzadeh; Amir Abbasnezhad; Mohammad Zeinali Khosroshahi; Razieh Choghakhori; Omid Asbaghi
Journal:  Endocrinol Metab (Seoul)       Date:  2019-06

7.  Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis.

Authors:  Elodie Lespagnol; Luc Dauchet; Mehdi Pawlak-Chaouch; Costantino Balestra; Serge Berthoin; Martin Feelisch; Matthieu Roustit; Julien Boissière; Pierre Fontaine; Elsa Heyman
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.